Track topics on Twitter Track topics that are important to you
A&G Pharmaceutical, Inc. (A&G) was incorporated in Delaware on June 6, 2000, as a "C" Corporation, to make use of two proprietary technologies that are unique to the Company. A&G is located in Baltimore, Maryland, and consists of two distinct but integrate divisions: 1) the Pharmaceutical Division and 2) the Monoclonal Antibody Services Division.
Breast cancer is the most common and most fatal malignancy for women worldwide. Overall, 15 percent of women will be diagnosed with breast cancer during their lifetime. Although breast cancer may initially be hormone-dependent and treated with anti-estrogen therapy such as tamoxifen, metastatic breast cancer will recur in 50 percent of patients within 5 years of initial treatment. The survival rate of women receiving chemotherapy is 10 to 20 percent after 5 years.
The first FDA-approved biological therapy for metastatic breast cancer, Genentech's Herceptin, was launched very successfully in 1998. Herceptin, the first antibody-based cancer therapy, is a humanized monoclonal antibody that represses erbB2. It is used as a therapeutic agent to treat patients with metastatic breast cancer over-expressing erbB2, which constitutes only 20 percent of all metastatic breast cancers. Currently, there is no similar clinical treatment for breast cancer patients not over-expressing erbB2.
Recently, A&G co-founder Dr. Ginette Serrero has cloned the novel growth factor PCDGF that is over-expressed in all metastatic breast cancers. It has been shown that inhibiting PCDGF expression or action leads to a 98 percent inhibition of human breast tumor formation in experimental animals. A&G has successfully obtained the exclusive patent rights to develop both diagnostic tools and therapeutic agents using monoclonal anti-PCDGF antibodies to address the market need for treating metastatic non-erbB2 breast cancers.
Monoclonal Antibody Services Division
A&G owns a proprietary technology that enables A&G to provide its customers the fastest monoclonal antibody production service in the industry (60 days versus an average of 180 days) and with the highest success rate (85 percent compared to an industry average of 25 percent). The Monoclonal Antibody Services Division is also developing monoclonal antibodies to key growth factors/receptors for licensing.
600E Lombard St., Suite 511
United States of America
CINCINNATI, OH / ACCESSWIRE / June 2, 2017 / M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or "M Pharma"), is pleased to announce that it has engaged Camargo Pharmaceutic...
STA Pharmaceutical, a subsidiary of China-based WuXi AppTec, has merged its operations with the parent company’s pharmaceutical development services (PDS) division.
Sun Pharmaceutical Industries has announced the acquisition of a 15.91% stake in Krystal Biotech for $7m.
NewsCURE Pharmaceutical announces entrance into booming pharmaceutical cannabis industry.Contributed Author:
CINCINNATI, OH / ACCESSWIRE / August 1, 2017 / M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2) ("M Pharma"), announces today that to better align with its expertise in the healthcare field...
This innovation is driving profits, competition, and market growth: Singapore's pharmaceutical industry is estimated to be worth more than USD 800 million by 2020. In a recent article titled Top 1...
Uppsala, Sweden, 2017-09-11 22:05 CEST (GLOBE NEWSWIRE) -- Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, hereby issues a no...
Pharmaceutical Development Group (PDG) provides pharmaceutical regulatory consulting to firms located around the world.
Surface-enhanced Raman spectroscopy (SERS) is a sensitive analytical tool used in the pharmaceutical field in recent years. SERS keeps all the advantages of classical Raman spectroscopy while being is...
Chapter issued by the United States Pharmacopeial Convention, Inc. is the standard for sterile compounding. It is designed to reduce the number of patient infections due to contaminated pharmaceutica...
Poorly soluble and/or permeable molecules jeopardize the discovery and development of innovative medicines. Pharmaceutical co-crystals, formed by an active pharmaceutical substance (API) and a co-crys...
Drug therapy plays a critical role in most chronic diseases. Effectiveness of pharmaceutical care services in the improvement of clinical, social, or economic outcomes has been scientifically proven t...
Due to a lack of pharmaceutical care (PC)-specific measures for health-related quality of life, a novel generic questionnaire "Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality o...
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...
The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...
The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...
The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.
PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...
Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono ...
PRAECIS PHARMACEUTICALS INCORPORATED is a biotechnology company focused on the discovery and development of pharmaceutical products using its proprietary LEAP™ (Ligand Evolution to Active Pharmaceut...
Founded in 2008 by the Axis Biotec Brasilâ¢ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....
COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...
We have published hundreds of A&G Pharmaceutical Incorporated news stories on BioPortfolio along with dozens of A&G Pharmaceutical Incorporated Clinical Trials and PubMed Articles about A&G Pharmaceutical Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of A&G Pharmaceutical Incorporated Companies in our database. You can also find out about relevant A&G Pharmaceutical Incorporated Drugs and Medications on this site too.
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Track and monitor developments in breast cancer research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...